Breaking News, Promotions & Moves

Affinia Therapeutics Names New Chief Business & Financial Officer

Rami Daoud is a seasoned biopharma executive with a successful track record in business development and biotech finance and corporate strategy.

Author Image

By: Charlie Sternberg

Associate Editor

Affinia Therapeutics, an innovative company with a proprietary platform pioneering a shift to a new class of rationally-designed gene therapies for rare and prevalent devastating diseases, has appointed Rami Daoud, M.B.A., as Chief Business and Financial Officer.   “Affinia is delighted to welcome Rami as our Chief Business and Financial Officer,” said Rick Modi, Affinia’s CEO. “Rami is a seasoned biopharma executive with a successful track record in business developmen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters